Else Nutrition Adds New Production Facility, Starts Commercial Production
2023年9月6日 - 6:01AM
ELSE NUTRITION HOLDINGS INC.
(BABY)
(BABYF)
(0YL.F) ("Else" or the
"Company"), announces that it has started
commercial production at a new US facility in the Mid West, which
will be able to support the company’s manufacturing demand in the
coming years in North America. The new US production facility will
lower costs while improving product quality.
Else completed production tests and scaleup in
July and ran the first commercial production of its lead product,
Toddler Organic, in August. In the coming months, the company
intends to complete trials for the rest of its products in North
America and enter a long-term supply agreement.
The significant cost reduction will start
impacting immediately the cash flow, and the company’s COGS towards
the end of 2023, as inventory from the previous plant is
depleted.
The quality of the produced product has also
improved at the new facility, making the product easier to package,
and dissolve better when mixed with water.
“I am very happy to announce this new production
facility,” said Hamutal Yitzhak, CEO, and Co-Founder of Else
Nutrition. “It materially increases our manufacturing capacity to a
level that will support significant growth in the coming years,
while reducing our COGS and improving the quality of the product.
It secures our ability to supply the current and anticipated
increase in demand for our products and will positively impact our
COGS significantly.”
For more information, visit: www.elsenutrition.com or follow
Else Nutrition on
LinkedIn
About Else Nutrition Holdings
Inc.
Else Nutrition Holdings Inc. (TSX: BABY, OTCQX:
BABYF, FSE: 0YL) is a food and nutrition company in the
international expansion stage focused on developing innovative,
clean, and plant-based food and nutrition products for infants,
toddlers, children, and adults. Its revolutionary, plant-based,
non-soy formula is a clean-ingredient alternative to dairy-based
formulas. Since launching its Plant-Based Complete Nutrition for
Toddlers, made of whole foods, almonds, buckwheat, and tapioca, the
brand has received thousands of powerful testimonials and reviews
from parents, gained national retailer support, and achieved rapid
sales growth.
Awards and Recognition:
-
"2017 Best Health and Diet Solutions" award at Milan's Global Food
Innovation Summit
-
#1 Best Seller on Amazon in the Fall of 2020 in the New Baby &
Toddler Formula Category
-
“Best Dairy Alternative” Award 2021 at World Plant-Based Expo
-
Nexty Award Finalist at Expo West 2022 in the Plant-Based lifestyle
category
-
During September 2022, Else Super Cereal reached the #1 Best Seller
in Baby Cereal across all brands on Amazon
Investor Relations Contact:Lytham Partners, LLC
Mr. Ben Shamsian New York | PhoenixE: shamsian@lythampartners.com
P: 646-829-9701
TSX Venture Exchange
Neither the TSX Venture Exchange nor its
regulation services provider (as that term is defined in the
policies of the TSX Venture Exchange) accept responsibility for the
adequacy or accuracy of this release.
Caution Regarding Forward-Looking
Statements
This press release contains statements that may
constitute "forward-looking statements" within the meaning of
applicable securities legislation. Forward-looking statements are
typically identified by words such as "will" or similar
expressions. Forward-looking statements in this press release
include statements with respect to the anticipated dates for filing
the company's financial disclosure documents. Such forward-looking
statements reflect current estimates, beliefs, and assumptions,
which are based on 'management's perception of current conditions
and expected future developments, as well as other factors
management believes are appropriate in the circumstances. No
assurance can be given that the foregoing will prove to be correct.
Forward-looking statements made in this press release assume, among
others, the expectation that there will be no interruptions or
supply chain failures as a result of COVID-19 and that the
manufacturing, broker, and supply logistic agreement with the
company does not terminate. Actual results may differ from the
estimates, beliefs, and assumptions expressed or implied in the
forward-looking statements. Readers are cautioned not to place
undue reliance on any forward-looking statements, which reflect
management's expectations only as of the date of this press
release. The company disclaims any obligation to update or revise
any forward-looking statements, whether as a result of new
information, future events, or otherwise, except as required by
law.
Else Nutrition (TSX:BABY)
過去 株価チャート
から 4 2024 まで 5 2024
Else Nutrition (TSX:BABY)
過去 株価チャート
から 5 2023 まで 5 2024